These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1741748)

  • 1. Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.
    Jones J; Morgan BP
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):199-204. PubMed ID: 1741748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
    Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
    J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.
    Jiang SB; Persechini PM; Zychlinsky A; Liu CC; Perussia B; Young JD
    J Exp Med; 1988 Dec; 168(6):2207-19. PubMed ID: 3199067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins.
    Jiang SB; Ojcius DM; Persechini PM; Young JD
    J Immunol; 1990 Feb; 144(3):998-1003. PubMed ID: 2104915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin).
    Young JD; Damiano A; DiNome MA; Leong LG; Cohn ZA
    J Exp Med; 1987 May; 165(5):1371-82. PubMed ID: 3494808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.
    Persechini PM; Young JD; Almers W
    J Cell Biol; 1990 Jun; 110(6):2109-16. PubMed ID: 1693622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforin and lymphocyte-mediated cytolysis.
    Liu CC; Persechini PM; Young JD
    Immunol Rev; 1995 Aug; 146():145-75. PubMed ID: 7493752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
    Lehmann C; Zeis M; Schmitz N; Uharek L
    Blood; 2000 Jul; 96(2):594-600. PubMed ID: 10887123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasts from cytotoxic T lymphocytes are resistant to perforin-mediated lysis.
    Ojcius DM; Jiang SB; Persechini PM; Detmers PA; Young JD
    Mol Immunol; 1991 Sep; 28(9):1011-8. PubMed ID: 1922107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis.
    Ojcius DM; Muller S; Hasselkus-Light CS; Young JD; Jiang S
    Immunol Lett; 1991 May; 28(2):101-8. PubMed ID: 1885208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin binding to cells and lipid membranes determined by a simple competition assay.
    Jiang SB; Ojcius DM; Young JD
    J Immunol Methods; 1990 Jan; 126(1):29-37. PubMed ID: 2303723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin.
    Müller C; Tschopp J
    J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies detecting discrete epitopes of human perforin.
    Geisberg M; Trapani JA; Dupont B
    Tissue Antigens; 1990 May; 35(5):229-33. PubMed ID: 1698318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells.
    Kawasaki A; Shinkai Y; Kuwana Y; Furuya A; Iigo Y; Hanai N; Itoh S; Yagita H; Okumura K
    Int Immunol; 1990; 2(7):677-84. PubMed ID: 2278998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity.
    Lowin B; Beermann F; Schmidt A; Tschopp J
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11571-5. PubMed ID: 7972104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: resistance to the pore forming protein of cytotoxic lymphocytes--perforin.
    Bisaggio Rda C; de Castro SL; Barbosa HS; Brandão Cde A; Persechini PM
    Exp Parasitol; 1997 Jun; 86(2):144-54. PubMed ID: 9207744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative susceptibility of peripheral blood leucocytes and related cell lines to killing by T-cell perforin.
    Jones J; Morgan BP
    Immunology; 1994 Aug; 82(4):555-60. PubMed ID: 7835917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of perforin in murine natural killer cells and cytotoxic T lymphocytes in vivo.
    Kawasaki A; Shinkai Y; Yagita H; Okumura K
    Eur J Immunol; 1992 May; 22(5):1215-9. PubMed ID: 1577064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.